Gynecology/Obstetrics CME

Credits: 0.50 CME / NCPD / CPE
Purdue University College of Pharmacy
Analyzing the Pros and Cons of Standard and Alternative Dosing Regimens of Immunotherapies and Combinations in Modern Oncology Practice
May 11, 2021
Credits: 1.50 CME / MOC / CC
Medical Learning Institute, Inc.
Target Practice: Understanding How PARP Inhibitors Take Aim at DNA Damage Response Mutations Across Solid Tumors
May 7, 2021
Credits: 0.50 CME
Medical Learning Institute, Inc.
Acute Hepatic Porphyria: Disease Diagnosis and Revelations Regarding the Role of siRNA Therapy
April 15, 2021
Credits: 1.00 CME / MOC / CC
Medical Learning Institute, Inc.
HER2 and HER3 Alterations as Therapeutic Targets of Increasing Significance in Solid Tumors: Implications for Pathology and Oncology Practice
April 6, 2021
Credits: 1.00 CME / MOC / CC
Medical Learning Institute, Inc.
The Nuances of Immunotherapy Biomarker Testing in Solid Tumors: Unraveling Complexities and Overcoming Challenges to Improve Outcomes
April 5, 2021
Credits: 0.50 CME / MOC / CE
Medical Learning Institute, Inc.
Innovative Blood-Based Screening in Cancer Care: State of the Science and Future Opportunities for Accelerating Cancer Diagnoses
March 18, 2021
Credits: 0.50 CME
Medical Learning Institute, Inc.
MS Treatment Decisions Before, During, and After Pregnancy: Focus on the Use of Disease-Modifying Therapies
January 22, 2021
Credits: 1.00 CME
Medical Learning Institute, Inc.
Realizing the Potential of CDK 4/6 Inhibitor Therapy in Breast Cancer: An Examination of the Evidence That Is Informing Real-World Practice
September 30, 2020
Credits: 1.00 CNE
Medical Learning Institute, Inc.
Rethinking Patient Care in Endometrial and Cervical Cancer: How Nurses Can Lead the Targeted and Immunotherapeutic Revolution
August 5, 2020
Credits: 1.00 CME
Medical Learning Institute, Inc.
Current and Emerging Therapies for Endometriosis and Uterine Fibroids: What Do You Need to Know?
August 3, 2020
Credits: 1.00 CME / MOC
Medical Learning Institute, Inc.
Evidence Informing Practice: Changing Standards of Care for Use of CDK4 and 6 Inhibitors in the Treatment of Breast Cancer
July 23, 2020
Credits: 1.00 CME / MOC
Medical Learning Institute, Inc.
Optimizing Precision Medicine in Ovarian Cancer: Expert Insights on Clinical Implications of PARP Inhibitor Therapy and Companion Diagnostics
July 21, 2020
Credits: 1.00 CME / MOC
Medical Learning Institute, Inc.
Practical Perspectives on Rapid Change in Endometrial and Cervical Cancer Management: Exploring Innovative Therapy in Gynecologic Malignancies
July 17, 2020
Credits: 0.50 CME / MOC
Medical Learning Institute, Inc.
Chair's Take on Harnessing the Immune System in the Treatment of TNBC and Beyond: Where Are We Now and Where Are We Going Next?
July 9, 2020
Credits: 0.50 CME / MOC
Medical Learning Institute, Inc.
Chair's Take: Latest and Emerging Evidence of PARP Inhibitors in Ovarian Cancer Management
June 18, 2020
Credits: 0.50 CME / MOC
Medical Learning Institute, Inc.
Chair’s Take on Advances in Gynecologic Cancer Care: Exploring New Advances and Innovative Therapies in Endometrial and Cervical Cancers
June 16, 2020
Medical Learning Institute, Inc.
Expert Views on the Evolving Role of PARP Inhibitors in the Treatment of Ovarian Cancer
April 30, 2020
Penn State College of Medicine
Advances in Precision Care in Solid Tumor Oncology: Defining the Role of PARP Inhibitors
November 8, 2019